|
1
|
Yin Y, Liu H, Wang F, Li L, Deng M, Huang
L and Zhao X: Transplantation of cryopreserved human umbilical cord
blood-derived endothelial progenitor cells induces recovery of
carotid artery injury in nude rats. Stem Cell Res Ther. 6:372015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhu S, Malhotra A, Zhang L, Deng S, Zhang
T, Freedman NJ, Storms R, Peppel K, Goldschmidt-Clermont PJ and
Dong C: Human umbilical cord blood endothelial progenitor cells
decrease vein graft neointimal hyperplasia in SCID mice.
Atherosclerosis. 212:63–69. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ke X, Shu XR, Wu F, Hu QS, Deng BQ, Wang
JF and Nie RQ: Overexpression of the β2AR gene improves function
and re-endothelialization capacity of EPCs after arterial injury in
nude mice. Stem Cell Res Ther. 7:732016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Briasoulis A, Tousoulis D, Antoniades C,
Papageorgiou N and Stefanadis C: The role of endothelial progenitor
cells in vascular repair after arterial injury and atherosclerotic
plaque development. Cardiovasc Ther. 29:125–139. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fadini GP, Coracina A, Baesso I, Agostini
C, Tiengo A, Avogaro A and de Kreutzenberg SV: Peripheral blood
CD34+KDR+ endothelial progenitor cells are determinants of
subclinical atherosclerosis in a middle-aged general population.
Stroke. 37:2277–2282. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lau KK, Chan YH, Yiu KH, Li SW, Tam S, Lau
CP, Kwong YL and Tse HF: Burden of carotid atherosclerosis in
patients with stroke: Relationships with circulating endothelial
progenitor cells and hypertension. J Human Hypertens. 21:445–451.
2007. View Article : Google Scholar
|
|
7
|
Lin H, Pan S, Meng L, Zhou C, Jiang C, Ji
Z, Chi J and Guo H: MicroRNA-384-mediated Herpud1 upregulation
promotes angiotensin II-induced endothelial cell apoptosis. Biochem
Biophys Res Commun. 488:453–460. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Calò LA, Facco M, Davis PA, Pagnin E, Maso
LD, Puato M, Caielli P, Agostini C and Pessina AC: Endothelial
progenitor cells relationships with clinical and biochemical
factors in a human model of blunted angiotensin II signaling.
Hypertens Res. 34:1017–1022. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Parzonko A, Czerwińska ME, Kiss AK and
Naruszewicz M: Oleuropein and oleacein may restore biological
functions of endothelial progenitor cells impaired by angiotensin
II via activation of Nrf2/heme oxygenase-1 pathway. Phytomedicine.
20:1088–1094. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wong KH, Li GQ, Li KM, Razmovski-Naumovski
V and Chan K: Kudzu root: Traditional uses and potential medicinal
benefits in diabetes and cardiovascular diseases. J Ethnopharmacol.
134:584–607. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Prasain JK, Peng N, Rajbhandari R and Wyss
JM: The Chinese Pueraria root extract (Pueraria lobata) ameliorates
impaired glucose and lipid metabolism in obese mice. Phytomedicine.
20:17–23. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Teng Y, Cui H, Yang M, Song H, Zhang Q, Su
Y and Zheng J: Protective effect of puerarin on diabetic
retinopathy in rats. Mol Biol Rep. 36:1129–1133. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Meng XH, Ni C, Zhu L, Shen YL, Wang LL and
Chen YY: Puerarin protects against high glucose-induced acute
vascular dysfunction: Role of heme oxygenase-1 in rat thoracic
aorta. Vascul Pharmacol. 50:110–115. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hu W, Zhang Q, Yang X, Wang Y and Sun L:
Puerarin inhibits adhesion molecule expression in
tnf-alpha-stimulated human endothelial cells via modulation of the
nuclear factor kappaB pathway. Pharmacology. 85:27–35. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen G, Pan SQ, Shen C, Pan SF, Zhang XM
and He QY: Puerarin inhibits angiotensin II-induced cardiac
hypertrophy via the redox-sensitive ERK1/2, p38 and NF-kappaB
pathways. Acta Pharmacol Sin. 35:463–475. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hill JM, Zalos G, Halcox JP, Schenke WH,
Waclawiw MA, Quyyumi AA and Finkel T: Circulating endothelial
progenitor cells, vascular function, and cardiovascular risk. N
Engl J Med. 348:593–600. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Parzonko A, Oswit A, Bazylko A and
Naruszewicz M: Anthocyans-rich Aronia melanocarpa extract possesses
ability to protect endothelial progenitor cells against angiotensin
II induced dysfunction. Phytomedicine. 22:1238–1246. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li X, Lin Y, Zhou H, Li Y, Wang A, Wang H
and Zhou MS: Puerarin protects against endothelial dysfunction and
end-organ damage in Ang II-induced hypertension. Clin Exp
Hypertens. 39:58–64. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gong X, Shao L, Fu YM and Zou Y: Effects
of olmesartan on endothelial progenitor cell mobilization and
function in carotid atherosclerosis. Med Sci Monit. 21:1189–1193.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yoder MC: Endothelial progenitor cell: A
blood cell by many other names may serve similar functions. J Mol
Med (Berl). 91:285–295. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bian F, Cui J, Zheng T and Jin S: Reactive
oxygen species mediate angiotensin II-induced transcytosis of
low-density lipoprotein across endothelial cells. Int J Mol Med.
2017. View Article : Google Scholar
|
|
22
|
Li W, Li Z, Chen Y, Li S, Lv Y, Zhou W,
Liao M, Zhu F, Zhou Z, Cheng X, et al: Autoantibodies targeting AT1
receptor from patients with acute coronary syndrome upregulate
proinflammatory cytokines expression in endothelial cells involving
NF-κB pathway. J Immunol Res. 2014:3426932014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Han T, Liu M and Yang S: DJ-1 alleviates
angiotensin II-induced endothelial progenitor cell damage by
activating the PPARγ/HO-1 pathway. J Cell Biochem. 119:392–400.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiong FL, Sun XH, Gan L, Yang XL and Xu
HB: Puerarin protects rat pancreatic islets from damage by hydrogen
peroxide. Eur J Pharmacol. 529:1–7. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yan LP, Zhuang YL, Chan SW, Chen SL and
Shi GG: Analysis of the mechanisms underlying the
endothelium-dependent antivasoconstriction of puerarin in rat
aorta. Naunyn Schmiedebergs Arch Pharmacol. 379:587–597. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hsu FL, Liu IM, Kuo DH, Chen WC, Su HC and
Cheng JT: Antihyperglycemic effect of puerarin in
streptozotocin-induced diabetic rats. J Nat Prod. 66:788–792. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lu XL, Liu JX, Wu Q, Long SM, Zheng MY,
Yao XL, Ren H, Wang YG, Su WW and Fai Cheung RT: Protective effects
of puerarin against Aß40-induced vascular dysfunction in zebrafish
and human endothelial cells. Eur J Pharmacol. 732:76–85. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ji L, Du Q, Li Y and Hu W: Puerarin
inhibits the inflammatory response in atherosclerosis via
modulation of the NF-κB pathway in a rabbit model. Pharmacol Rep.
68:1054–1059. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chang CC, Chu CF, Wang CN, Wu HT, Bi KW,
Pang JH and Huang ST: The anti-atherosclerotic effect of tanshinone
IIA is associated with the inhibition of TNF- α-induced VCAM-1,
ICAM-1 and CX3CL1 expression. Phytomedicine. 21:207–216. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Spigoni V, Picconi A, Cito M, Ridolfi V,
Bonomini S, Casali C, Zavaroni I, Gnudi L, Metra M and Dei Cas A:
Pioglitazone improves in vitro viability and function of
endothelial progenitor cells from individuals with impaired glucose
tolerance. Plos One. 7:e482832012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hwang YP, Kim HG, Hien TT, Jeong MH, Jeong
TC and Jeong HG: Puerarin activates endothelial nitric oxide
synthase through estrogen receptor-dependent PI3-kinase and
calcium-dependent AMP-activated protein kinase. Toxicol Appl
Pharmacol. 257:48–58. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kang OH, Kim SB, Mun SH, Seo YS, Hwang HC,
Lee YM, Lee HS, Kang DG and Kwon DY: Puerarin ameliorates hepatic
steatosis by activating the PPARalpha and AMPK signaling pathways
in hepatocytes. Int J Mol Med. 35:803–809. 2015. View Article : Google Scholar : PubMed/NCBI
|
